HUP9902208A3 - Polymorphic forms of a growth hormone secretagogue and medicaments containing them - Google Patents
Polymorphic forms of a growth hormone secretagogue and medicaments containing themInfo
- Publication number
- HUP9902208A3 HUP9902208A3 HU9902208A HUP9902208A HUP9902208A3 HU P9902208 A3 HUP9902208 A3 HU P9902208A3 HU 9902208 A HU9902208 A HU 9902208A HU P9902208 A HUP9902208 A HU P9902208A HU P9902208 A3 HUP9902208 A3 HU P9902208A3
- Authority
- HU
- Hungary
- Prior art keywords
- growth hormone
- polymorphic forms
- medicaments containing
- hormone secretagogue
- secretagogue
- Prior art date
Links
- 102100033367 Appetite-regulating hormone Human genes 0.000 title 1
- 101710111255 Appetite-regulating hormone Proteins 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 239000003324 growth hormone secretagogue Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
- Fodder In General (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US590095P | 1995-10-27 | 1995-10-27 | |
| GBGB9603361.8A GB9603361D0 (en) | 1996-02-16 | 1996-02-16 | Polymorphic forms of a growth hormone secretagogue |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP9902208A2 HUP9902208A2 (hu) | 1999-10-28 |
| HUP9902208A3 true HUP9902208A3 (en) | 2001-05-28 |
Family
ID=26308741
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9902208A HUP9902208A3 (en) | 1995-10-27 | 1996-10-23 | Polymorphic forms of a growth hormone secretagogue and medicaments containing them |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP1019402A1 (xx) |
| JP (1) | JP3204266B2 (xx) |
| KR (1) | KR19990067098A (xx) |
| CN (1) | CN1067687C (xx) |
| AU (1) | AU707946B2 (xx) |
| BG (1) | BG102476A (xx) |
| BR (1) | BR9611229A (xx) |
| CA (1) | CA2235371A1 (xx) |
| CO (1) | CO4770956A1 (xx) |
| CZ (1) | CZ128098A3 (xx) |
| EA (1) | EA000528B1 (xx) |
| EE (1) | EE9800147A (xx) |
| HK (1) | HK1017894A1 (xx) |
| HU (1) | HUP9902208A3 (xx) |
| IS (1) | IS4721A (xx) |
| NO (1) | NO310556B1 (xx) |
| NZ (1) | NZ321370A (xx) |
| PL (1) | PL327511A1 (xx) |
| SK (1) | SK51398A3 (xx) |
| TR (1) | TR199800726T2 (xx) |
| WO (1) | WO1997015574A1 (xx) |
| YU (1) | YU56696A (xx) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6046333A (en) * | 1996-10-25 | 2000-04-04 | Merck & Co., Inc. | Convergent process for the preparation of a growth hormone secretagogue |
| US9119832B2 (en) | 2014-02-05 | 2015-09-01 | The Regents Of The University Of California | Methods of treating mild brain injury |
| WO2017075535A1 (en) | 2015-10-28 | 2017-05-04 | Oxeia Biopharmaceuticals, Inc. | Methods of treating neurodegenerative conditions |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ151495A3 (en) * | 1992-12-11 | 1995-12-13 | Merck & Co Inc | Spiropiperidine derivatives, process of their preparation and a pharmaceutical composition containing thereof |
-
1996
- 1996-10-23 AU AU74686/96A patent/AU707946B2/en not_active Expired
- 1996-10-23 NZ NZ321370A patent/NZ321370A/xx not_active IP Right Cessation
- 1996-10-23 KR KR1019980703038A patent/KR19990067098A/ko not_active Application Discontinuation
- 1996-10-23 EP EP96936869A patent/EP1019402A1/en not_active Withdrawn
- 1996-10-23 CZ CZ981280A patent/CZ128098A3/cs unknown
- 1996-10-23 EA EA199800335A patent/EA000528B1/ru not_active IP Right Cessation
- 1996-10-23 HU HU9902208A patent/HUP9902208A3/hu unknown
- 1996-10-23 TR TR1998/00726T patent/TR199800726T2/xx unknown
- 1996-10-23 CN CN96199328A patent/CN1067687C/zh not_active Expired - Lifetime
- 1996-10-23 PL PL96327511A patent/PL327511A1/xx unknown
- 1996-10-23 BR BR9611229A patent/BR9611229A/pt not_active IP Right Cessation
- 1996-10-23 EE EE9800147A patent/EE9800147A/xx unknown
- 1996-10-23 CA CA002235371A patent/CA2235371A1/en not_active Abandoned
- 1996-10-23 WO PCT/US1996/016955 patent/WO1997015574A1/en not_active Application Discontinuation
- 1996-10-23 SK SK513-98A patent/SK51398A3/sk unknown
- 1996-10-23 JP JP51673797A patent/JP3204266B2/ja not_active Expired - Lifetime
- 1996-10-25 YU YU56696A patent/YU56696A/sh unknown
- 1996-10-25 CO CO96056663A patent/CO4770956A1/es unknown
-
1998
- 1998-04-21 IS IS4721A patent/IS4721A/is unknown
- 1998-04-24 NO NO19981867A patent/NO310556B1/no not_active IP Right Cessation
- 1998-05-21 BG BG102476A patent/BG102476A/xx unknown
-
1999
- 1999-07-12 HK HK99102961A patent/HK1017894A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CZ128098A3 (cs) | 1998-09-16 |
| EA000528B1 (ru) | 1999-10-28 |
| JP3204266B2 (ja) | 2001-09-04 |
| SK51398A3 (en) | 1998-12-02 |
| JPH10512295A (ja) | 1998-11-24 |
| CO4770956A1 (es) | 1999-04-30 |
| EP1019402A1 (en) | 2000-07-19 |
| YU56696A (sh) | 1999-09-27 |
| CN1205703A (zh) | 1999-01-20 |
| NO981867D0 (no) | 1998-04-24 |
| NO310556B1 (no) | 2001-07-23 |
| MX9803351A (es) | 1998-09-30 |
| AU7468696A (en) | 1997-05-15 |
| CN1067687C (zh) | 2001-06-27 |
| WO1997015574A1 (en) | 1997-05-01 |
| EE9800147A (et) | 1998-12-15 |
| KR19990067098A (ko) | 1999-08-16 |
| NZ321370A (en) | 1999-11-29 |
| CA2235371A1 (en) | 1997-05-01 |
| EA199800335A1 (ru) | 1998-12-24 |
| BG102476A (en) | 1999-04-30 |
| BR9611229A (pt) | 1999-05-25 |
| NO981867L (no) | 1998-06-29 |
| AU707946B2 (en) | 1999-07-22 |
| PL327511A1 (en) | 1998-12-21 |
| HK1017894A1 (en) | 1999-12-03 |
| TR199800726T2 (xx) | 1998-08-21 |
| HUP9902208A2 (hu) | 1999-10-28 |
| IS4721A (is) | 1998-04-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA968989B (en) | Polymorphic forms of a growth hormone secretagogue | |
| ZA945463B (en) | Benzo-fused lactams promote release of growth hormone | |
| ZA937082B (en) | Benzo-fused lactams promote release of growth hormone | |
| ZA945462B (en) | Benzo-fused lactams promote release of growth hormone | |
| ZA937594B (en) | Benzo-fused lactams promote release of growth hormone | |
| ZA937222B (en) | Benzo-fused lactams promote release of growth hormone | |
| PL327397A1 (en) | Antagonists of a gonadothropin liberating hormone | |
| IL116743A0 (en) | Pharmaceutical composition comprising a growth hormone | |
| HUP9901718A3 (en) | Analogs of parathyroid hormone | |
| AU6122194A (en) | Benzo-fused lactams promote release of growth hormone | |
| AU7961694A (en) | Benzo-fused lactams promote release of growth hormone | |
| HU9601013D0 (en) | Combination of bisphosphonates and growth hormone secretagogues | |
| ZA949899B (en) | Heterocyclic-fused lactams promote release of growth hormone | |
| EP0741578A4 (en) | HUMAN GROWTH HORMONE | |
| EP0785784A4 (en) | HETEROCYCLIC PIPERIDINES IN POSITION 4 PROMOTING THE RELEASE OF GROWTH HORMONE | |
| HUP9800731A3 (en) | Stimulation of meiosis | |
| GB2320005B (en) | Orientation of cans | |
| AU1371895A (en) | Benzo-fused lactams promote release of growth hormone | |
| ZA944090B (en) | Process for asymmetic total synthesis of camptothecln analogues and intermediates prepared thereby | |
| EP0857020A4 (en) | FORMULATION OF SECRETAGOGUE STIMULATING THE SECRETION OF THE GROWTH HORMONE, INTENDED TO BE GRANULATED BY WET | |
| HUP9902095A3 (en) | New process for the preparation of a growth hormone secretagogue | |
| EP0815116A4 (en) | INHIBITING AND MODULATING THE ACTIVITY OF THE GONADOTROPIN RELEASE HORMONE RECEPTOR | |
| HUP9902208A3 (en) | Polymorphic forms of a growth hormone secretagogue and medicaments containing them | |
| GB9823422D0 (en) | Naptho-fused lactams promate release of growth hormone | |
| IL116742A0 (en) | Pharmaceutical composition comprising a growth hormone |